MedPath

Two-channel IV-PCA With Dexmedetomidine

Not Applicable
Recruiting
Conditions
Analgesia, Patient-Controlled
Dexmedetomidine
Interventions
Registration Number
NCT05672225
Lead Sponsor
Korea University Guro Hospital
Brief Summary

Dexmedetomidine was administered in the 'selector' channel and fentanyl in the 'basic \& bolus' channel of dual channel intravenous patient-controlled analgesia (IV-PCA) and the amount of opioid consumption was compared. In addition, intensity of pain, postoperative nausea/vomiting, and postoperative delirium was evaluated.

Detailed Description

Bellomic® (Cebika, Uiwang-si, Gyeonggi-do, South Korea), a new IV-PCA device consisting of two separate drug pump channels, can be used in various ways and is expanding its scope of use. Unlike conventional IV-PCA devices, which have been used to mix and administer all drugs in one channel, the device can inject drugs separately in two channels. One channel (Selector \& Bolus) allows the patient to control whether to take additional bolus medication by pressing the button with adjustable continuous infusion, while the other channel (Continuous) allows constant rate continuous infusion.

Dexmedetomidine is a selective alpha-2 agonist, which is widely used in intensive care unit management, surgery, and various procedures because it has the advantage of less respiratory suppression along with sedation/anesthesia and pain effects. It has been previously reported that postoperative pain, morphine usage, and nausea/vomiting can be reduced when used during/after surgery in addition to general anesthetic drugs. However, in terms of major abdominal surgery, there is no research related to the use of dexmedetomidine after surgery, even though a large amount of opioid agents are required due to severe acute pain.

Thus, the investigators planned a randomized controlled trial to investigate the effectiveness dexmedetomidine using dual-chamber IV-PCA.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
110
Inclusion Criteria
  • Patients who was scheduled for laparoscopic major abdominal surgery (Gastrectomy, Hepatectomy, Colectomy, Pancreatectomy) under general anesthesia
  • Aged ≥ 20 years old
Exclusion Criteria
  • Body mass index ≥35 kg/m2
  • American Society of Anesthesiologists physical status > 3
  • Severe cardiovascular disorder
  • Severe liver or renal dysfunction
  • Preoperative dyspnea
  • Contraindication to dexmedetomidine (preoperative severe bradycardia (Heart rate <50), atrioventricular block, allergy to dexmedetomidine)
  • Preoperative use of opioid, anticonvulsant, antidepressant

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control groupControlContinuous channel: normal saline 100ml, 2ml/h (fixed rate) Selector \& Bolus channel: fentanyl 20mcg/kg (Total 50ml with normal saline), bolus 1ml/10min lock-out
Dexmedetomidine groupDexmedetomidineContinuous channel: dexmedetomidine 10mcg/kg (Total 100ml with normal saline), 2ml/h (fixed rate) Selector \& Bolus channel: fentanyl 20mcg/kg (Total 50ml with normal saline), bolus 1ml/10min lock-out
Primary Outcome Measures
NameTimeMethod
Fentanyl consumption during 24 hours24 hours after surgery

Cumulative consumption of fentanyl during 24 hours

Secondary Outcome Measures
NameTimeMethod
Additional analgesic consumption at post-anesthesia care unit1 hour after surgery

Opioid, NSAID, or acetaminophen consumption

Adverse events during 1,6,24,48 hours1,6,24,48 hours after surgery

Nausea, vomiting, hypotension, sedation, respiratory depression, pruritus

Rescue analgesic consumption at 1,6,24,48 hours1,6,24,48 hours after surgery

Additional opioid, NSAID, or acetaminophen consumption

Satisfaction score at 24 hours24 hours after surgery

Satisfaction score evaluated with quality of recovery (QoR)-15 (0\[poor\] to 10\[excellent\]), 7-pointed Likert scale (1 \[very dissatisfied\]- 7\[very satisfied\])

Fentanyl consumption during 1,6,48 hours1,6,24,48 hours after surgery

Cumulative consumption of fentanyl during 1,6,48 hours

Pain scores at 1,6,24,48 hours1,6,24,48 hours after surgery

11-pointed numerical rating scale pain score (0 \[no pain\]-10 \[Extreme pain\])

Delirium during 1,6,24,48 hours1,6,24,48 hours after surgery

Confusion assessment method (CAM)-evaluated delirium

Trial Locations

Locations (1)

Korea University Guro Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath